Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mario Gabelli, Gamco Add to Stake in Edgen Group, Close Position in Rochester Medical

Mario Gabelli’s fund Gamco Investors disclosed upping its position in Edgen Group Inc (NYSE:EDG). The fund now holds an aggregate of 1.45 million shares, just after increasing the stake to 1.2 million disclosed in an earlier filing from last week. Following the acquisition of additional shares, Gamco now holds 7.66% of the outstanding shares of Edgen Group.

Mario Gabelli

Surprisingly enough, Gabelli’s bullishness on Edgen Group comes on the back on the recent announcement by the company, according to which Sumitomo Corporation, together with Sumitomo Corporation of America signed a definitive merger agreement with Edgen Group. Sumitomo plans to acquire Edgen for $12.0 in cash. The deal is yet to be approved by regulators and is expected to be completed by the end of 2013.

Mark Kingdon’s Kingdon Capital and Richard Driehaus Driehaus Capital, also hold large stakes in Edgen Group. Kingdon owns 603,256 shares, and Driehaus holds a $3.2 million stake, which amasses 506,554 shares, according to our database.

In a separate filing, Gamco reported that it no longer holds shares of Rochester Medical Corporation (NASDAQ:ROCM), following its acquisition by C.R. Bard, Inc. (NYSE:BCR). Gabelli has been loading up on shares of Rochester during the past months, increasing its position first to 944,000 shares, and later to 983,316 shares. Taking into account that C.R. Bard offered to pay $20.0 per share in cash, we can assume that the aggregate value of shares held by Gamco amounted to almost $19.7 million.

Rochester signed a definitive agreement with C.R. Bard at the beginning of the September. The latter offered $20 per share in cash, as stated below. The whole price of the deal amounts to $262 million. Rochester’s board approved the merger unanimously, and on November 13, the shareholders held a special meeting where they expressed their position regarding the deal.

Disclosure: none

Recommended Reading:

Coliseum Capital Buys Shares of Accuride Corporation at $3.23/Share

Lansdowne Partners Adds to Position in Tableau Software

Coghill Capital Sells Some Autobytel Shares

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!